The FDA has approved updated labeling for Rebif® (has approved updated labeling for Rebif® (interferon beta-1a; EMD Serono) to include the addition of new safety data on pregnancy and lactation.interferon beta-1a; EMD Serono) to include the addition of new safety data on pregnancy and lactation.
But no increase seen in conotruncal malformations, oral clefts with use of oral fluconazole in first trimester
The prescribing information for Plegridy® (peginterferon beta-1a; Biogen) and Avonex® (interferon beta-1a; Biogen) has been updated to include additional information related to pregnancy and lactation.
Exposure often occurs early in the pregnancy, likely before pregnancy has been recognized
According to the findings of a recent retrospective analysis, pregnancy and pregnancy-related adverse events related to isotretinoin administration have dropped since the initiation of the iPLEDGE program by the Food and Drug Administration (FDA) in 2006, however reports of fetal exposure persist. The iPLEDGE program is a Risk Evaluation and Mitigation Strategy (REMS) that aims…
Negative effects on cognitive, motor outcomes seen from age 6 months persist to school age
Progesterone administered in first trimester does not result in significantly more live births
Study authors say not only is influenza vaccine during pregnancy safe, it is necessary
Second bulletin provides recommendations for management of chronic hypertension in pregnancy
A physician report indicates that 4 placebo (non-hormonal) capsules were placed in the first 4 days of therapy instead of active capsules.
